Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: a review

References

• Harris EN. Maternal autoantibodies and pregnancy. In: The Antiphospholipid Syndrome Bailliere's Clinical Rheumatology 1990; 4:53–68.
   PubMed Web of Science ®Google Scholar
• Harris EN. Syndrome of the Black Swan. Br J Rheumatol 1987; 26:324–6.
   PubMedGoogle Scholar
• Nilsson IM, Astedt B, Hedner V, and Berezin D. Intra-uterine death and circulating anticoagulant (“antithromboplastin”). Acta Medica Scandinavica 1975; 197:153–9.
   PubMedGoogle Scholar
• Soulier JP, and Boffa MC. Avortments a répétition thrombosis et anticoagulant circulant antithromboplastin. Nouv. Press. Medical. 1980; 9:859–64.
   Google Scholar
• Carreras LO, Machin SJ, Deman R et al. Arterial thrombosis, intrauterine death and lupus anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; i:244–6.
   Google Scholar
• Hughes GRV. Thrombosis, abortion, cerebral lupus and lupus anticoagulant. Br Med J 1983; 287:1088–9.
   PubMed Web of Science ®Google Scholar
• Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211–4.
   Google Scholar
• Koike T, and Matsuura E. Anti-ß2glycoprotein 1 antibody: specificity and clinical significance. Lupus 1996; 5:378–80.
   PubMed Web of Science ®Google Scholar
• Roubey RAS. Antigenic specifities of antiphospholipid autoantibodies: implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome. Lupus 1996; 5:425–30.
   PubMed Web of Science ®Google Scholar
• DeWolf F, Carreras LO, Moerman P, et al. Decidual vasculopathy and extensive placental infarction in a patient with thromboembolic accidents, recurrent fetal loss and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142:829–34.
   PubMed Web of Science ®Google Scholar
• Lubbe WF, Palmer JJ, Butler WS, Liggins GC. Fetal survival after prednisone suppression of lupus anticoagulant. Lancet 1983; i:1361–3.
   Google Scholar
• Branch DW, Scott JR, Kochenour NK, et al. Obstetric-complications associated with lupus anticoagulant. New Eng J Med 1985; 313:1322–6.
   PubMed Web of Science ®Google Scholar
• Tincani A, Cattaneo R, Faden D, et al. Antiphospholipid antibodies in recurrent fetal loss: only one side of the coin. Clin Exp Rheumatol 1989; 7:390–1.
   Google Scholar
• Ordi J, Barquinero J, Vilardell M, et al. Fetal loss treatment in patients with antiphospholipid antibodies. Ann Rheum Dis 1989; 48:798–802.
   PubMed Web of Science ®Google Scholar
• Branch DW, Silver RM, Blackwell JL, et al. Outcome of treated pregnancies in women with Antiphospholipid Syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80:614–20.
   PubMed Web of Science ®Google Scholar
• Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989; 160:439–43.
   PubMed Web of Science ®Google Scholar
• Rosove MH, Tabsh K, Wasserstrum N, et al. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75:630–4.
   PubMed Web of Science ®Google Scholar
• Cowchock FS, Reece EA, Balaham D, et al. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone to low-dose heparin treatment. Am J Obstet Gynecol 1992; 166:1318–27.
   PubMed Web of Science ®Google Scholar
• McVerry BA, Spearing R, Smith A. SLE anticoagulant: Transient inhibition by high dose immunoglobulin infusions. Br J Haematol 1985; 61:579–80.
   PubMed Web of Science ®Google Scholar
• Tchemia G, Dreyfus M, Laurian Y, et al. Management of immune thrombocytopenia in pregnancy: response to infusions of immunoglobulins. Am J Obstet Gynecol 1984; 148:225–6.
   PubMed Web of Science ®Google Scholar
• Sultan Y, Kazatckine MD, Maissonneuve P, et al. Anti-idiotypic suppression of autoantibodies to factor VIR by high dose intravenous immunoglobulin. Lancet 1984; ii:765–8.
   Google Scholar
• Carreras LO, Perez GN, Vega HR, Casavilla F. Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet 1988; 2:393–4.
   PubMed Web of Science ®Google Scholar
• Orvieto R, Achiron A, Ben-Rafael Z, Achiron R. Intravenous immunoglobulin treatment for recurrent abortions caused by antiphospholipid antibodies. Fertil Steril 1991; 56:1013–20.
   PubMed Web of Science ®Google Scholar
• Scott JR, Branch DW, Kochenour NK, Ward K. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 1989; 159:1055–6.
   Web of Science ®Google Scholar
• Parke A, Maier D, Wilson D, et al. Intravenous gammaglobulin antiphospholipid antibodies, and pregnancy. Ann Intern Med 1989; 110:495–6.
   PubMed Web of Science ®Google Scholar
• Wapner RJ, Cowchock FS, Shapiro SS. Successful treatment in two women with antiphospholipid antibodies and refractory pregnancy losses with intravenous gammaglobulin infusions. Am J Obstet Gynecol 1989; 616:1271–2.
   Google Scholar
• Katz VL, Thorp JM, Watson WJ, et al. Human immunoglobulin therapy for preclampsia associated with high dose intravenous immunoglobulin. Obstet Gynecol 1990; 76:986–7.
   PubMed Web of Science ®Google Scholar
• Valensise H, Vaquero E, DeCarolis C, et al. Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin. Prenat Diagn 1995; 15:509–17.
   PubMed Web of Science ®Google Scholar
• Spinnato JA, Clark AL, Pierangeli SS, Harris EN. Intravenous immunoglobulin therapy for antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 1995; 172:690–4.
   PubMed Web of Science ®Google Scholar
• Amout J, Spitz B, Wittervrongel C, et al. High dose intravenous immunoglobulin treatment of a pregnant patient with antiphospholipid syndrome: inununological changes associated with a successful outcome. Thromb Haemost 1994; 71:741–7.
   PubMed Web of Science ®Google Scholar
• Dwyer JM. Manipulating the immune system with immunoglobulin. New Engl J Med 1992; 326:107–6.
   PubMed Web of Science ®Google Scholar
• Bakimer R, Guilbard B, Zurgh N, Shoenfeld Y. The effect of intravenous gammaglobulin (IVIg) on the induction of experimental APS. Clin Immunol Immunopathol 1993; 69(1):97–102.
   PubMedGoogle Scholar
• Clark AL, Gall SA. Clinical uses of intravenous immunoglobulin in pregnancy. Am J Obstet Gynecol 1997; 176:241–53.
   PubMed Web of Science ®Google Scholar